Vaccine Alliance To Fund Global Stockpile Of Ebola Vaccines

The video discusses a stockpile of 500,000 Ebola vaccines, a $178 million investment, available for free to poor and middle-income countries, with funding for vaccine campaigns. Wealthier countries must pay for access. Gavi, a public-private partnership, and WHO are involved in the vaccine's approval, ensuring quality and safety standards. The vaccine, manufactured by Merck, received European Commission approval. The current Ebola outbreak in Congo, ongoing since August, has caused over 2200 deaths, making it the second deadliest outbreak.

What is the significance of the WHO pre-qualifying the Ebola vaccine?

What has been the impact of the current Ebola outbreak in Congo?